An online initiative of the Cancer Institute NSW

Awareness, accessibility and adaptability of eviQ information and treatment protocols in clinical practice

Industry news
Share this page Email this page to a friend Share this page via Twitter Share this page via Facebook Share this page via LinkedIn

The future is exciting in the field of adolescent and young adult (AYA) cancer care with the inclusion of this specialty in the Cancer Institute NSW cancer treatments online website, eviQ.

Awareness, accessibility and adaptability of eviQ information and treatment protocols in clinical practice

eviQ is a point of care clinical information system that assists clinicians to deliver best practice cancer treatment and is available at www.eviQ.org.au. eviQ, formerly CI-SCaT, was created to reduce cancer treatment variation and improve equity of access to information.

Data governance

A data governance framework and reference committees of practising clinicians were established to provide a mechanism to transform tacit knowledge to explicit knowledge, integrate this into information and treatment protocols based on the best available evidence.

eviQ adheres to a governance process to ensure the quality of published information. Content is prioritised according to the following:

  • variation in practice,
  • variation in access to care, or
  • the availability of suitable data.

All requests for content are considered if they include legitimate treatments and meet the inclusion criteria. Content is developed through a review process beginning with a systematic literature review. Reference committee meetings allow for debate around issues of clinical treatment, benchmarking of practice and ensure content is applicable to the clinical setting.

Content is not placed on the website until consensus amongst the committee is reached. Content development is a rigorous and independent process. Annual surveillance for literature that could affect existing content is undertaken. This ensures all information is based on best available evidence and can be incorporated into clinical practice.

By embedding a strong data governance framework, and ensuring this framework is transparent to all users, eviQ can publish information and treatment protocols that blend evidence with the reality of clinical practice

Figure 1: eviQ Data Governance Framework
the eviQ data governance process flowchart. Multiple levels of expert review with inputs from variety of governing bodies in the health care sector.

AYA content stream

eviQ aims to improve the treatment and care of adolescent and young adults diagnosed with cancer by providing targeted, point of care information to fill the identified gaps in existing information available to health professionals, as identified by a national group of clinicians.

As a lot of excellent information is already available in the area of AYA cancer care, eviQ will also link to existing resources to provide a comprehensive online clinical information resource.

eviQ users around the world

From Botswana to Belgium, eviQ is being used in over 56 countries around the world, making up five percent of users. Canada, New Zealand and Ireland are the most frequent users outside Australia.

Figure 2: Map of World Usage
map showing over 56 countries around the world where eviQ is being used.

Who is using eviQ?

On average, there are around 49,000 hits on eviQ per day. Health professionals make up 95 per cent of eviQ users with patients/carers representing five per cent of total registrants. The mix of users across Australia is fairly consistent, with the two territories having slightly higher usage by patients and carers and Northern Territory having higher usage by primary health care professionals.

Figure 3: eviQ Users by Role
Chart showing percentage breakdown of eviQ users by their role in the cancer care sector.

About the authors

Rowena Nelson, Shelley Rushton and Sue Sinclair are employees of the Cancer Institute NSW

Robyn Ward is Professor of Medicine at Prince of Wales Hospital Sydney, and Program Director eviQ, Cancer Institute NSW

Top of page